The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Fecal microbiota transplantation in cancer management: Current status and perspectives
Open accessAbstract
The human gut is home to a large and diverse microbial community, comprising about 1,000 bacterial species. The gut microbiota exists in a symbiotic relationship with its host, playing a decisive role in the host's nutrition, immunity and metabolism. Accumulating studies have revealed the associations between gut dysbiosis or some special bacteria and various cancers. Emerging data suggest that gut microbiota can modulate the effectiveness of cancer therapies, especially immunotherapy. Manipulating the microbial populations with therapeutic intent has become a hot topic of cancer research, and the most dramatic manipulation of gut microbiota refers to fecal microbiota transplantation (FMT) from healthy individuals to patients. FMT has demonstrated remarkable clinical efficacy against Clostridium difficile infection (CDI) and it is highly recommended for the treatment of recurrent or refractory CDI. Lately, interest is growing in the therapeutic potential of FMT for other diseases, including cancers. We briefly reviewed the current researches about gut microbiota and its link to cancer, and then summarized the recent preclinical and clinical evidence to indicate the potential of FMT in cancer management as well as cancer‐treatment associated complications. We also presented the rationale of FMT for cancer management such as reconstruction of intestinal microbiota, amelioration of bile acid metabolism, and modulation of immunotherapy efficacy. This article would help to better understand this new therapeutic approach for cancer patients by targeting gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 2×
“Melanoma Gopalakrishnan et al.(71) 2018 Experimental study”
BackgroundCommensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 3×
“Several studies using melanoma-bearing mice showed that the effectiveness of programmed cell death protein 1 (PD-1) inhibitor was diminished under aseptic conditions,(71) and improved effectiveness was observed in the presence of Bifidobacterium, which activated antigen-presenting cells, thus promoting activated CD8+…”
BackgroundInfluentialDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 1×
“MCA205 (mouse fibrosarcoma of C57BL background) sarcoma growth was controlled by anticytotoxic T-lymphocyte-associated antigen 4 (CTLA -4) therapy in specific pathogen free laboratory mice, compared to germ-free or antibiotic-treated mice.(73) These studies highlight the impact of the intestinal microbiota on response…”
BackgroundGut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Signals from the gut microbiota to distant organs in physiology and disease
Schroeder, B. O., & Bäckhed, F. (2016) · Nature Medicine · doi:10.1038/nm.4185 · Cited by 1,409
Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286
Yu, J., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309800 · Cited by 1,253
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
Yang, Y., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,008
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
(1958) · PubMed · Cited by 978
Daillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Duong, C. P. M., Flament, C., Lepage, P., Roberti, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.009 · Cited by 897
Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888
Taur, Y., Jenq, R. R., Perales, M.-A., Littmann, E. R., Morjaria, S., Ling, L., No, D., Gobourne, A., Viale, A., Dahi, P. B., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554725 · Cited by 885
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Rosshart, S. P., Vassallo, B. G., Angeletti, D., Hutchinson, D. S., Morgan, A. P., Takeda, K., Hickman, H. D., McCulloch, J. A., Badger, J. H., Ajami, N. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.016 · Cited by 862
Helicobacter pylori-induced gastric inflammation and gastric cancer
Wang, F., Meng, W., Wang, B., & Qiao, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.08.016 · Cited by 793
Self-citationThe microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aar6918 · Cited by 777
Frankel, A. E., Coughlin, L. A., Kim, J., Froehlich, T. W., Xie, Y., Frenkel, E. P., & Koh, A. Y. (2017) · Neoplasia · doi:10.1016/j.neo.2017.08.004 · Cited by 709
Fan, X., Alekseyenko, A. V., Wu, J., Peters, B. A., Jacobs, E. J., Gapstur, S. M., Purdue, M. P., Abnet, C. C., Stolzenberg-Solomon, R., Miller, G., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312580 · Cited by 702
Self-citationGastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Ferreira, R. M., Pereira-Marques, J., Pinto-Ribeiro, I., Costa, J. L., Carneiro, F., Machado, J. C., & Figueiredo, C. (2018) · Gut · doi:10.1136/gutjnl-2017-314205 · Cited by 697
Mucosal microbiome dysbiosis in gastric carcinogenesis
Coker, O. O., Dai, Z., Nie, Y., Zhao, G., Cao, L., Nakatsu, G., Wu, W. K., Wong, S. H., Chen, Z., Sung, J. J. Y., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314281 · Cited by 695
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Choi, I. J., Kook, M.-C., Kim, Y.-I., Cho, S.-J., Lee, J. Y., Kim, C. G., Park, B., & Nam, B.-H. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1708423 · Cited by 673
Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., Aroniadis, O., Barto, A., Borody, T., Giovanelli, A., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.133 · Cited by 636
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Wong, S. H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T. N. Y., Tsoi, H., Wu, W. K. K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.022 · Cited by 634
The microbiome of the urinary tract—a role beyond infection
Whiteside, S. A., Razvi, H., Dave, S., Reid, G., & Burton, J. P. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.361 · Cited by 633
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., Kheradman, R., Heuman, D., Wang, J., Gurry, T., et al. (2017) · Hepatology · doi:10.1002/hep.29306 · Cited by 633
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Antibiotics as deep modulators of gut microbiota: between good and evil
Ianiro, G., Tilg, H., & Gasbarrini, A. (2016) · Gut · doi:10.1136/gutjnl-2016-312297 · Cited by 625
Should we standardize the 1,700-year-old fecal microbiota transplantation?
Zhang, F., Luo, W., Shi, Y., Fan, Z., & Ji, G. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.251 · Cited by 619
Kao, D., Roach, B., Silva, M., Beck, P., Rioux, K., Kaplan, G. G., Chang, H.-J., Coward, S., Goodman, K. J., Xu, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.17077 · Cited by 615
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Llopis, M., Cassard, A. M., Wrzosek, L., Boschat, L., Bruneau, A., Ferrere, G., Puchois, V, Martin, J. C., Lepage, P., Le Roy, T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310585 · Cited by 560
Colonization of the Human Gut by E. coli and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475
A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer
Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., & Soyletir, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01494.x · Cited by 454
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
Schulz, M. D., Atay, Ç., Heringer, J., Romrig, F. K., Schwitalla, S., Aydin, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., et al. (2014) · Nature · doi:10.1038/nature13398 · Cited by 453
Ijssennagger, N., Belzer, C., Hooiveld, G. J., Dekker, J., van Mil, S. W. C., Müller, M., Kleerebezem, M., & van der Meer, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507645112 · Cited by 443
Tsoi, H., Chu, E. S. H., Zhang, X., Sheng, J., Nakatsu, G., Ng, S. C., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.009 · Cited by 438
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
Zhou, D., Pan, Q., Shen, F., Cao, H.-X., Ding, W.-J., Chen, Y.-W., & Fan, J.-G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01751-y · Cited by 421
Self-citationSystematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161174 · Cited by 409
Self-citationGut microbiota promotes tumor growth in mice by modulating immune response
Sethi, V., Kurtom, S., Tarique, M., Lavania, S., Malchiodi, Z., Hellmund, L., Zhang, L., Sharma, U., Giri, B., Garg, B., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.001 · Cited by 403
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 402
Kakihana, K., Fujioka, Y., Suda, W., Najima, Y., Kuwata, G., Sasajima, S., Mimura, I., Morita, H., Sugiyama, D., Nishikawa, H., et al. (2016) · Blood · doi:10.1182/blood-2016-05-717652 · Cited by 367
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Philips, C. A., Pande, A., Shasthry, S. M., Jamwal, K. D., Khillan, V., Chandel, S. S., Kumar, G., Sharma, M. K., Maiwall, R., Jindal, A., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.029 · Cited by 349
Dhiman, R. K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K. K., Khattri, A., Malhotra, S., Duseja, A., & Chawla, Y. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.031 · Cited by 339
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D. J., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 332
Faecal microbiota transplantation protects against radiation‐induced toxicity
Cui, M., Xiao, H., Li, Y., Zhou, L., Zhao, S., Luo, D., Zheng, Q., Dong, J., Zhao, Y., Zhang, X., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606932 · Cited by 328
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
Ferrere, G., Wrzosek, L., Cailleux, F., Turpin, W., Puchois, V., Spatz, M., Ciocan, D., Rainteau, D., Humbert, L., Hugot, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.008 · Cited by 324
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Distrutti, E., Monaldi, L., Ricci, P., & Fiorucci, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2219 · Cited by 320
Gerassy-Vainberg, S., Blatt, A., Danin-Poleg, Y., Gershovich, K., Sabo, E., Nevelsky, A., Daniel, S., Dahan, A., Ziv, O., Dheer, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-313789 · Cited by 318
Wong, S. H., Kwong, T. N. Y., Chow, T.-C., Luk, A. K. C., Dai, R. Z. W., Nakatsu, G., Lam, T. Y. T., Zhang, L., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312766 · Cited by 310
Self-citationOchi, A., Nguyen, A. H., Bedrosian, A. S., Mushlin, H. M., Zarbakhsh, S., Barilla, R., Zambirinis, C. P., Fallon, N. C., Rehman, A., Pylayeva-Gupta, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111706 · Cited by 304
Cui, B., Feng, Q., Wang, H., Wang, M., Peng, Z., Li, P., Huang, G., Liu, Z., Wu, P., Fan, Z., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12727 · Cited by 298
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology · doi:10.1002/hep.26695 · Cited by 279
Hsieh, Y.-Y., Tung, S.-Y., Pan, H.-Y., Yen, C.-W., Xu, H.-W., Lin, Y.-J., Deng, Y.-F., Hsu, W.-T., Wu, C.-S., & Li, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18596-0 · Cited by 269
Boursi, B., Mamtani, R., Haynes, K., & Yang, Y.-X. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.015 · Cited by 263
Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14173 · Cited by 258
Cao, H., Liu, X., An, Y., Zhou, G., Liu, Y., Xu, M., Dong, W., Wang, S., Yan, F., Jiang, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10835-8 · Cited by 253
Self-citationProbiotic Strain Lactobacillus casei BL23 Prevents Colitis‐Associated Colorectal Cancer
Jacouton, E., Chain, F., Sokol, H., Langella, P., & Bermúdez-Humarán, L. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01553 · Cited by 249
Yong, X., Tang, B., Li, B.-S., Xie, R., Hu, C.-J., Luo, G., Qin, Y., Dong, H., & Yang, S.-M. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0111-0 · Cited by 235
Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development
Kumar, R., Herold, J. L., Schady, D., Davis, J., Kopetz, S., Martinez-Moczygemba, M., Murray, B. E., Han, F., Li, Y., Callaway, E., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006440 · Cited by 234
Fecal microbiota transplantation broadening its application beyond intestinal disorders
Xu, M.-Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.102 · Cited by 231 · cited 1×
“Moreover, accumulating data indicate that FMT proves beneficial for the treatment of inflammatory bowel diseases and intractable functional constipation, etc.(21,22) In addition, the observed intestinal dysbiosis in cancer leads to increasing interests in the potential of FMT for the management of cancer.”
BackgroundCao, H., Xu, M., Dong, W., Deng, B., Wang, S., Zhang, Y., Wang, S., Luo, S., Wang, W., Qi, Y., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30643 · Cited by 231
Self-citationThe intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease
Staffas, A., Burgos da Silva, M., & van den Brink, M. R. M. (2017) · Blood · doi:10.1182/blood-2016-09-691394 · Cited by 208
Wu, S., Powell, J., Mathioudakis, N., Kane, S., Fernandez, E., & Sears, C. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5832-5839.2004 · Cited by 203
Relapsing Clostridium difficile Enterocolitis Cured by Rectal Infusion of Normal Faeces
Schwan, A., Sjolin, S., Trottestam, U., & Aronsson, B. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087145 · Cited by 201
RELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECES
SCHWAN, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90753-5 · Cited by 196
Xie, Y.-H., Gao, Q.-Y., Cai, G.-X., Sun, X.-M., Zou, T.-H., Chen, H.-M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X.-Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 194
Long-term use of antibiotics and risk of colorectal adenoma
Cao, Y., Wu, K., Mehta, R., Drew, D. A., Song, M., Lochhead, P., Nguyen, L. H., Izard, J., Fuchs, C. S., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313413 · Cited by 192
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., & Gorvel, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.171 · Cited by 189
Jiang, Z. D., Ajami, N. J., Petrosino, J. F., Jun, G., Hanis, C. L., Shah, M., Hochman, L., Ankoma‐Sey, V., DuPont, A. W., Wong, M. C., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13969 · Cited by 182
Preoperative Probiotics Decrease Postoperative Infectious Complications of Colorectal Cancer
Zhang, J.-W., Du, P., Yang, B.-R., Gao, J., Fang, W.-J., & Ying, C.-M. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31823aace6 · Cited by 177
Ren, Y., Ye, Z., Yang, L., Jin, L., Wei, W., Deng, Y., Chen, X., Xiao, C., Yu, X., Xu, H., et al. (2017) · Hepatology · doi:10.1002/hep.29008 · Cited by 171
Schwartz, M., Gluck, M., & Koon, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.164 · Cited by 162
Lactobacillus acidophilus Could Modulate the Immune Response Against Breast Cancer in Murine Model
Maroof, H., Hassan, Z. M., Mobarez, A. M., & Mohamadabadi, M. A. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9708-x · Cited by 159
The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease
Boleij, A., & Tjalsma, H. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70107-5 · Cited by 158
Role of bacterial infections in pancreatic cancer
Michaud, D. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt249 · Cited by 156
Wang, L., Cao, H., Liu, L., Wang, B., Walker, W. A., Acra, S. A., & Yan, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553800 · Cited by 155
Self-citation(2015) · PubMed · Cited by 152
Han, S. H., Suk, K. T., Kim, D. J., Kim, M. Y., Baik, S. K., Kim, Y. D., Cheon, G. J., Choi, D. H., Ham, Y. L., Shin, D. H., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000458 · Cited by 149
Bajaj, J. S., Kakiyama, G., Savidge, T., Takei, H., Kassam, Z., Fagan, A., Gavis, E. A., Pandak, W. M., Nittono, H., Hylemon, P. B., et al. (2018) · Hepatology · doi:10.1002/hep.30037 · Cited by 149
Costello, S. P., Conlon, M. A., Vuaran, M. S., Roberts-Thomson, I. C., & Andrews, J. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13366 · Cited by 144
Goedert, J. J., Hua, X., Bielecka, A., Okayasu, I., Milne, G. L., Jones, G. S., Fujiwara, M., Sinha, R., Wan, Y., Xu, X., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.435 · Cited by 144
Yang, J., Tan, Q., Fu, Q., Zhou, Y., Hu, Y., Tang, S., Zhou, Y., Zhang, J., Qiu, J., & Lv, Q. (2016) · Breast Cancer · doi:10.1007/s12282-016-0734-z · Cited by 143
GUT BACTERIA AND ÆTIOLOGY OF CANCER OF THE BREAST
Hill, M. J., Goddard, P., & Williams, R. E. O. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92634-1 · Cited by 140
Fecal microbiota transplantation in the management of hepatic encephalopathy
Kao, D. H., Roach, B., Park, H., Hotte, N., Madsen, K. L., Bain, V. G., & Tandon, P. (2015) · Hepatology · doi:10.1002/hep.28121 · Cited by 139
The microbiome and hepatobiliary-pancreatic cancers
Mima, K., Nakagawa, S., Sawayama, H., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., Baba, Y., Yamashita, Y., Yoshida, N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.001 · Cited by 139
Dik, V. K., van Oijen, M. G. H., Smeets, H. M., & Siersema, P. D. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3828-0 · Cited by 128
Doorakkers, E., Lagergren, J., Engstrand, L. G., & Brusselaers, N. (2018) · Gut · doi:10.1136/gutjnl-2017-315363 · Cited by 122
Webb, B. J., Brunner, A., Ford, C. D., Gazdik, M. A., Petersen, F. B., & Hoda, D. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12550 · Cited by 118
Probiotics Clostridium Butyricum and Bacillus Subtilis Ameliorate Intestinal Tumorigenesis
Chen, Z., Ai, L., Wang, J., Ren, L.-L., Yu, Y., Xu, J., Chen, H., Yu, J. Q., Li, M., Qin, W., et al. (2015) · Future Microbiology · doi:10.2217/fmb.15.66 · Cited by 116
Wang, W., Zhang, Y., Huang, X., You, N., Zheng, L., & Li, J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i38.6983 · Cited by 116
Neemann, K., Eichele, D. D., Smith, P. W., Bociek, R., Akhtari, M., & Freifeld, A. (2012) · Transplant Infectious Disease · doi:10.1111/tid.12017 · Cited by 107
Dias-Jácome, E., Libânio, D., Borges‐Canha, M., Galaghar, A., & Pimentel‐Nunes, P. (2016) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2016.4261/2016 · Cited by 100
Impact of antibiotic exposure on the risk of colorectal cancer
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 96
Wang, J., Chang, C., Lin, J., Wu, L., Chuang, L., & Lai, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28738 · Cited by 76
Khan, S., Zakariah, M., Rolfo, C. D., Lembrechts, R., & Palaniappan, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8306 · Cited by 74
Khan, S., Imran, A., Khan, A. A., Kalam, M. A., & Alshamsan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148530 · Cited by 73
Association betweenHelicobacterspp. infections and hepatobiliary malignancies: A review
López, F. K. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1414 · Cited by 67
Hefazi, M., Patnaik, M. M., Hogan, W. J., Litzow, M. R., Pardi, D. S., & Khanna, S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.08.016 · Cited by 66
Ricci, V. (2016) · Toxins · doi:10.3390/toxins8070203 · Cited by 64
Cancer and the microbiome: potential applications as new tumor biomarker
Shahanavaj, K., Bazo, I. G., Castiglia, M., Bronte, G., Passiglia, F., Carreca, A. P., del Pozo, J. L., Russo, A. D., Peeters, M., & Rolfo, C. D. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.992785 · Cited by 62
Liang, S., Xu, L., Zhang, D., & Wu, Z. (2016) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2016.15375 · Cited by 62
Fecal microbiota transplant after hematopoietic SCT: report of a successful case
de Castro, C. G., Ganc, A. J., Ganc, R. L., Petrolli, M., & Hamerschlack, N. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.212 · Cited by 60
Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases
Malhi, H., & Camilleri, M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.09.008 · Cited by 54
Kaur, K., Saxena, A., Debnath, I., O’Brien, J. L., Ajami, N. J., Auchtung, T. A., Petrosino, J. F., Sougiannis, A.-J. T., Depaep, S., Chumanevich, A. A., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1460 · Cited by 54
Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer
Khan, S. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.002 · Cited by 50
Khan, S., Zakariah, M., & Palaniappan, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-4970-9 · Cited by 49
The gastrointestinal microbiota and its role in oncogenesis
Lam, S. Y., Yu, J. Q., Wong, S. H., Peppelenbosch, M. P., & Fuhler, G. M. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.010 · Cited by 47
Mittal, C., Miller, N., Meighani, A., Hart, B. R., John, A., & Ramesh, M. S. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.85 · Cited by 28
Mashima, H., Suzuki, J., Hirayama, T., Yoshikumi, Y., Ohno, H., Ohnishi, H., Yasuda, H., Fujita, T., & Omata, M. (2008) · Infection and Immunity · doi:10.1128/iai.01573-07 · Cited by 26
Searching for superstool: maximizing the therapeutic potential of FMT
Olesen, S. W., Leier, M., Alm, E. J., & Kahn, S. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0019-4 · Cited by 26
Oncologists tap the microbiome in bid to improve immunotherapy outcomes
Mullard, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.19 · Cited by 23
Qin, C., Zhang, H., Zhao, L., Zeng, M., Huang, W., Fu, G., Zhou, W., Wang, H., & Yan, H. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9202-0 · Cited by 19
Kim, J. S., Ward, K. K., Shah, N. R., Saenz, C. C., McHale, M. T., & Plaxe, S. C. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1888-2 · Cited by 16
Faecal microbiota transplantation in clinical practice
Terveer, E. M., van Beurden, Y. H., Goorhuis, A., Mulder, C. J. J., Kuijper, E. J., & Keller, J. J. (2017) · Gut · doi:10.1136/gutjnl-2017-313909 · Cited by 16
Trubiano, J. A., George, A., Barnett, J., Siwan, M., Heriot, A. G., Prince, H. M., Slavin, M. A., & Teh, B. W. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.920503 · Cited by 15
Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment
Blackburn, L. M., Bales, A., Caldwell, M., Cordell, L., Hamilton, S., & Kreider, H. (2015) · Clinical journal of oncology nursing · doi:10.1188/15.cjon.111-114 · Cited by 12
Banking on stool despite an uncertain future
Amirtha, T. (2016) · Science · doi:10.1126/science.352.6291.1261 · Cited by 8
Cited by
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
Chen, D., Jin, D., Huang, S., Wu, J., Xu, M., Liu, T., Dong, W., Liu, X., Wang, S., Zhong, W., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.019 · Cited by 495
Self-citationGut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Chrysostomou, D., Roberts, L. A., Marchesi, J. R., & Kinross, J. M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2022.10.018 · Cited by 283
Hazan, S. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925930 · Cited by 200
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies
Oster, P., Vaillant, L., Riva, E., McMillan, B., Begka, C., Truntzer, C., Richard, C., Leblond, M. M., Messaoudene, M., Machremi, E., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323392 · Cited by 176
Metadata
- Authors
- Chen, D., Wu, J., Jin, D., Wang, B., & Cao, H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2018-12-30
- Volume
- 145
- Issue
- 8
- Pages
- 2021-2031
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2900720258
- Cited by
- 321
- References
- 137
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.